Generic-Drug Developer Lannett Plans Prepack Chapter 11 Bankruptcy Filing
Wall Street Journal
Publicly-traded drugmaker says it will enter bankruptcy with a plan to cut its debt load by over $500 million with strong secured creditor support
Understanding current events through the lenses of the past and future.
Wall Street Journal
Publicly-traded drugmaker says it will enter bankruptcy with a plan to cut its debt load by over $500 million with strong secured creditor support